Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
AI Wellness Stock Targeting Massive Growth (CSE: ALEN.U) (click to learn more) Cannabis Investors Are Watching Herbal Dispatch (CSE:HERB) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Monopar Therapeutics Inc MNPR

Healthcare Biotechnology
Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors... see more

Current News (NDAQ:MNPR)

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

GlobeNewswire November 13, 2025

Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025

GlobeNewswire November 9, 2025

Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025

GlobeNewswire October 15, 2025

Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire September 23, 2025

Monopar Announces Journal of Hepatology Publishes Physicians' Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients

GlobeNewswire September 23, 2025

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting

GlobeNewswire September 14, 2025

Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting

GlobeNewswire September 3, 2025

Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments

GlobeNewswire August 12, 2025

Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers

GlobeNewswire June 11, 2025
View More News ››

Opinion & Analysis (NDAQ:MNPR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:MNPR)

Monopar Therapeutics Inc. (NASDAQ:MNPR): Laser-Focused on Ad

http://beyondspx.com/2024/08/02/monopar-therapeutics-inc-nasdaqmnpr-laser-focused-on-advancing-its-promising-radiopharmaceutical-pipeline...
MikeTester - August 3, 2024

MNPR ..... Let's go Baby !

over $1.00 now
Iseneschal - July 14, 2023

MNPR ..... No Position ; )

Chers !
Iseneschal - July 14, 2023

MNPR ..... on watch

early a.m runner was in PB mode......now back thru resistance at $0.97.....rarely seen with these Chitco Co's on NASDAQ....usually...
Iseneschal - July 14, 2023

watching this one for

a possible purchase,off my watchlist,it is cheap but getting a bit cheaper,so glta.
coolfooldumbguy - January 14, 2020
View more Bullboard ››

Sekur Private Data Ltd.

Sekur Private Data Ltd.

Sekur Private Data Ltd. operates as a cybersecurity and internet privacy provider of Swiss hosted solutions for secure ...
View More »

Podcasts